Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes

Journal of Biological Chemistry

Volumn 287, Issue 6, 2012, Pages 3617-3629

  Busnelli, Marta ^a,b   Saulière, Aude ^c   Manning, Maurice ^d   Bouvier, Michel ^e   Galés, Celine ^c   Chini, Bice ^a  

^a CNR   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c University Hospital of Toulouse   (France)

^d MEDICAL COLLEGE OF OHIO   (United States)

^e INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARRESTINS; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; G PROTEIN; PHYSIOLOGICAL RESPONSE; PROTEIN SIGNALING; PSYCHIATRIC DISORDERS; SELECTIVE LIGANDS; SOCIAL BEHAVIOR;

BIOSENSORS; CELL PROLIFERATION; LIGANDS; PEPTIDES; PHYSIOLOGICAL MODELS;

CHEMICAL ACTIVATION;

ATOSIBAN; BETA ARRESTIN; DNALOVT PEPTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; OXYTOCIN; OXYTOCIN RECEPTOR; PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTERNALIZATION; LIGAND BINDING; MALE; PRIORITY JOURNAL;

ANIMALS; AUTISTIC DISORDER; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME ACTIVATION; GTP-BINDING PROTEINS; HEK293 CELLS; HORMONE ANTAGONISTS; HUMANS; OXYTOCICS; OXYTOCIN; RECEPTORS, OXYTOCIN; VASOTOCIN;

EID: 84856759440     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.277178     Document Type: Article

References (51)

1. Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., Miller, K. J., Spedding, M., and Mailman, R. B. (2007) Functional selectivity and classical concepts of quantitative pharmacology. J. Pharmacol. Exp. Ther. 320, 1-13 (Pubitemid 46025713)
2. Zhou, X. B., Lutz, S., Steffens, F., Korth, M., and Wieland, T. (2007) Oxytocin receptors differentially signal via Gq and Gi proteins in pregnant and nonpregnant rat uterine myocytes: implications for myometrial contractility. Mol. Endocrinol. 21, 740-752
3. Strakova, Z., and Soloff, M. S. (1997) Coupling of oxytocin receptor to G proteins in rat myometrium during labor: Gi receptor interaction. Am. J. Physiol. 272, E870-E876
4. Gravati, M., Busnelli, M., Bulgheroni, E., Reversi, A., Spaiardi, P., Parenti, M., Toselli, M., and Chini, B. (2010) Dual modulation of inward rectifier potassium currents in olfactory neuronal cells by promiscuous G protein coupling of the oxytocin receptor. J. Neurochem. 114, 1424-1435
5. Rimoldi, V., Reversi, A., Taverna, E., Rosa, P., Francolini, M., Cassoni, P., Parenti, M., and Chini, B. (2003) Oxytocin receptor elicits different EGFR/ MAPK activation patterns depending on its localization in caveolin-1 enriched domains. Oncogene 22, 6054-6060 (Pubitemid 37175883)
6. Sanborn, B. M. (2001) Hormones and calcium: mechanisms controlling uterine smooth muscle contractile activity: the Litchfield Lecture. Exp. Physiol. 86, 223-237
7. Guzzi, F., Zanchetta, D., Cassoni, P., Guzzi, V., Francolini, M., Parenti, M., and Chini, B. (2002) Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response. Oncogene 21, 1658-1667 (Pubitemid 34259029)
8. Reversi, A., Rimoldi, V., Marrocco, T., Cassoni, P., Bussolati, G., Parenti, M., and Chini, B. (2005) The oxytocin receptor antagonist atosiban inhibits cell growth via a "biased agonist" mechanism. J. Biol. Chem. 280, 16311-16318 (Pubitemid 40616759)
9. Zhong, M., Boseman, M. L., Millena, A. C., and Khan, S. A. (2010) Oxytocin induces the migration of prostate cancer cells: involvement of the Gi-coupled signaling pathway. Mol. Cancer Res. 8, 1164-1172
10. Cassoni, P., Sapino, A., Papotti, M., and Bussolati, G. (1996) Oxytocin and oxytocin analogue F314 inhibit cell proliferation and tumor growth of rat and mouse mammary carcinomas. Int. J. Cancer 66, 817-820 (Pubitemid 26199175)
11. Insel, T. R. (2010) The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron 65, 768-779
12. Kuehn, B. M. (2011) Scientists probe oxytocin therapy for social deficits in autism, schizophrenia. JAMA 305, 659-661
13. Galés, C., Van Durm, J. J., Schaak, S., Pontier, S., Percherancier, Y., Audet, M., Paris, H., and Bouvier, M. (2006) Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. Nat. Struct. Mol. Biol. 13, 778-786 (Pubitemid 44338771)
14. Chini, B., Mouillac, B., Ala, Y., Balestre, M. N., Trumpp-Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., Manning, M., and Jard, S. (1995) Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor. EMBO J. 14, 2176-2182
15. Albertazzi, E., Zanchetta, D., Barbier, P., Faranda, S., Frattini, A., Vezzoni, P., Procaccio, M., Bettinelli, A., Guzzi, F., Parenti, M., and Chini, B. (2000) Nephrogenic diabetes insipidus: functional analysis of new AVPR2 mutations identified in Italian families. J. Am. Soc. Nephrol. 11, 1033-1043 (Pubitemid 30367933)
16. Terrillon, S., Durroux, T., Mouillac, B., Breit, A., Ayoub, M. A., Taulan, M., Jockers, R., Barberis, C., and Bouvier, M. (2003) Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol. Endocrinol. 17, 677-691 (Pubitemid 36403579)
17. Dupré, D. J., Robitaille, M., Richer, M., Ethier, N., Mamarbachi, A. M., and Hébert, T. E. (2007) Dopamine receptor-interacting protein 78 acts as a molecular chaperone for Gγ subunits before assembly with Gβ. J. Biol. Chem. 282, 13703-13715
18. Azzi, M., Charest, P. G., Angers, S., Rousseau, G., Kohout, T., Bouvier, M., and Piñeyro, G. (2003) β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations forGprotein-coupled receptors. Proc. Natl. Acad. Sci. U.S.A. 100, 11406-11411 (Pubitemid 37205948)
19. Perroy, J., Adam, L., Qanbar, R., Chénier, S., and Bouvier, M. (2003) Phosphorylation- independent desensitization of GABA(B) receptor by GRK4. EMBO J. 22, 3816-3824 (Pubitemid 36980593)
20. Manning, M., Stoev, S., Chini, B., Durroux, T., Mouillac, B., and Guillon, G. (2008) Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Prog. Brain Res. 170, 473-512 (Pubitemid 352014896)
21. Manning, M., Cheng, L. L., Stoev, S., Wo, N. C., Chan, W. Y., Szeto, H. H., Durroux, T., Mouillac, B., and Barberis, C. (2005) Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban. J. Pept. Sci. 11, 593-608 (Pubitemid 41489004)
22. Conti, F., Sertic, S., Reversi, A., and Chini, B. (2009) Intracellular trafficking of the human oxytocin receptor: evidence of receptor recycling via a Rab4/Rab5 "short cycle". Am. J. Physiol. Endocrinol. Metab. 296, E532-E542
23. Chini, B., Mouillac, B., Ala, Y., Balestre, M. N., Cotte, N., Trumpp- Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., and Manning, M. (1995) Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family. Adv. Exp. Med. Biol. 395, 321-328
24. Mouillac, B., Chini, B., Balestre, M. N., Elands, J., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Jard, S., and Barberis, C. (1995) The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions. J. Biol. Chem. 270, 25771-25777
25. Galés, C., Rebois, R. V., Hogue, M., Trieu, P., Breit, A., Hébert, T. E., and Bouvier, M. (2005) Real-time monitoring of receptor and G-protein interactions in living cells. Nat. Methods 2, 177-184 (Pubitemid 41122124)
26. Audet, N., Galés, C., Archer-Lahlou, E., Vallières, M., Schiller, P. W., Bouvier, M., and Pineyro, G. (2008) Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing δ-opioid receptors and heterotrimeric G proteins. J. Biol. Chem. 283, 15078-15088
27. De, A., Loening, A. M., and Gambhir, S. S. (2007) An improved bioluminescence resonance energy transfer strategy for imaging intracellular events in single cells and living subjects. Cancer Res. 67, 7175-7183 (Pubitemid 47206545)
28. Loening, A. M., Fenn, T. D., Wu, A. M., and Gambhir, S. S. (2006) Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output. Protein Eng. Des. Sel 19, 391-400 (Pubitemid 44306057)
29. Shenoy, S. K., and Lefkowitz, R. J. (2005) Seven-transmembrane receptor signaling through β-arrestin. Sci. STKE 2005, cm10
30. Jean-Alphonse, F., Perkovska, S., Frantz, M. C., Durroux, T., Méjean, C., Morin, D., Loison, S., Bonnet, D., Hibert, M., Mouillac, B., and Mendre, C. (2009) Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus. J. Am. Soc. Nephrol. 20, 2190-2203
31. Groer, C. E., Tidgewell, K., Moyer, R. A., Harding, W. W., Rothman, R. B., Prisinzano, T. E., and Bohn, L. M. (2007) An opioid agonist that does not induce μ-opioid receptor-arrestin interactions or receptor internalization. Mol. Pharmacol. 71, 549-557 (Pubitemid 46147920)
32. Angers, S., Salahpour, A., Joly, E., Hilairet, S., Chelsky, D., Dennis, M., and Bouvier, M. (2000) Detection of β2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc. Natl. Acad. Sci. U.S.A. 97, 3684-3689 (Pubitemid 30183363)
33. Hasbi, A., Devost, D., Laporte, S. A., and Zingg, H. H. (2004) Real-timedetection of interactions between the human oxytocin receptor and G protein-coupled receptor kinase-2. Mol. Endocrinol. 18, 1277-1286 (Pubitemid 38591291)
34. Cassoni, P., Marrocco, T., Sapino, A., Allia, E., and Bussolati, G. (2004) Evidence of oxytocin/oxytocin receptor interplay in human prostate gland and carcinomas. Int. J. Oncol. 25, 899-904
35. Phaneuf, S., Europe-Finner, G. N., Varney, M., MacKenzie, I. Z., Watson, S. P., and López Bernal, A. (1993) Oxytocin-stimulated phosphoinositide hydrolysis in human myometrial cells: involvement of pertussis toxinsensitive and -insensitive G-proteins. J. Endocrinol. 136, 497-509 (Pubitemid 23142216)
36. Hawtin, S. R., Ha, S. N., Pettibone, D. J., and Wheatley, M. (2005) A Gly/ Ala switch contributes to high affinity binding of benzoxazinone-based non-peptide oxytocin receptor antagonists. FEBS Lett. 579, 349-356 (Pubitemid 40092411)
37. Postina, R., Kojro, E., and Fahrenholz, F. (1998) Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling. Adv. Exp. Med. Biol. 449, 371-385 (Pubitemid 28566411)
38. Chini, B., Mouillac, B., Balestre, M. N., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Andriolo, M., Pupier, S., Jard, S., and Barberis, C. (1996) Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin. FEBS Lett. 397, 201-206 (Pubitemid 26414017)
39. Fanelli, F., Barbier, P., Zanchetta, D., De Benedetti, P. G., and Chini, B. (1999) Activation mechanism of human oxytocin receptor: a combined study of experimental and computer-simulated mutagenesis. Mol. Pharmacol. 56, 214-225 (Pubitemid 29309831)
40. Favre, N., Fanelli, F., Missotten, M., Nichols, A., Wilson, J., di Tiani, M., Rommel, C., and Scheer, A. (2005) The DRY motif as a molecular switch of the human oxytocin receptor. Biochemistry 44, 9990-10008 (Pubitemid 41076795)
41. Rajagopal, S., Rajagopal, K., and Lefkowitz, R. J. (2010) Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug. Discov. 9, 373-386
42. Oakley, R. H., Laporte, S. A., Holt, J. A., Barak, L. S., and Caron, M. G. (2001) Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-β-arrestin complexes after receptor endocytosis. J. Biol. Chem. 276, 19452-19460
43. Smith, M. P., Ayad, V. J., Mundell, S. J., McArdle, C. A., Kelly, E., and López Bernal, A. (2006) Internalization and desensitization of the oxytocin receptor is inhibited by dynamin and clathrin mutants in human embryonic kidney 293 cells. Mol. Endocrinol. 20, 379-388 (Pubitemid 43152511)
44. Leduc, M., Breton, B., Galés, C., Le Gouill, C., Bouvier, M., Chemtob, S., and Heveker, N. (2009) Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands. J. Pharmacol. Exp. Ther. 331, 297-307
45. 12, and β-arrestin 1. FASEB J. 24, 3522-3535
46. i1 protein complex measured by bioluminescence resonance energy transfer in living cells. Mol. Pharmacol. 71, 1329-1340
47. Lane, J. R., Powney, B., Wise, A., Rees, S., and Milligan, G. (2007) Protean agonism at the dopamine D2 receptor: (S)-3-(3-hydroxyphenyl)-N- propylpiperidine is an agonist for activation of Go1 but an antagonist/inverse agonist for Gi1, Gi2, and Gi3. Mol. Pharmacol. 71, 1349-1359 (Pubitemid 46658688)
48. Misra, S., Murthy, K. S., Zhou, H., and Grider, J. R. (2004) Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways. J. Pharmacol. Exp. Ther. 311, 1154-1162 (Pubitemid 39612723)
49. Garibay, J. L., Kozasa, T., Itoh, H., Tsukamoto, T., Matsuoka, M., and Kaziro, Y. (1991) Analysis by mRNA levels of the expression of six G protein α-subunit genes in mammalian cells and tissues. Biochim. Biophys. Acta 1094, 193-199
50. Chini, B., Chinol, M., Cassoni, P., Papi, S., Reversi, A., Areces, L., Marrocco, T., Paganelli, G., Manning, M., and Bussolati, G. (2003) Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue. Br. J. Cancer 89, 930-936 (Pubitemid 37175818)
51. Gimpl, G., Postina, R., Fahrenholz, F., and Reinheimer, T. (2005) Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin. Eur. J. Pharmacol. 510, 9-16 (Pubitemid 40312384)